Staphylococcus aureus is a major cause of skin and
soft tissue infection. The bacterium expresses four major
proteases that are emerging as
virulence factors:
aureolysin (Aur), V8
protease (SspA), staphopain A (
ScpA), and staphopain B (SspB). We hypothesized that human
galectin-3, a β-galactoside-binding
lectin involved in immune regulation and antimicrobial defense, is a target for these
proteases and that proteolysis of
galectin-3 is a novel immune evasion mechanism. Indeed, supernatants from laboratory strains and clinical isolates of S. aureus caused
galectin-3 degradation. Similar proteolytic capacities were found in Staphylococcus epidermidis isolates but not in Staphylococcus saprophyticus Galectin-3-induced activation of the neutrophil
NADPH oxidase was abrogated by bacterium-derived proteolysis of
galectin-3, and SspB was identified as the major
protease responsible. The impact of
galectin-3 and
protease expression on S. aureus virulence was studied in a murine skin
infection model. In
galectin-3+/+ mice, SspB-expressing S. aureus caused larger lesions and resulted in higher bacterial loads than
protease-lacking bacteria. No such difference in bacterial load or lesion size was detected in
galectin-3-/- mice, which overall showed smaller lesion sizes than the
galectin-3+/+ animals. In conclusion, the
staphylococcal protease SspB inactivates
galectin-3, abrogating its stimulation of
oxygen radical production in human neutrophils and increasing tissue damage during skin
infection.